Abstract:Disrupting NMDA receptor signaling by PSD95‐nNOS protein–protein interactions inhibitors blocked morphine‐induced CPP, attenuated morphine‐induced increases in DA efflux and reduced morphine relapse. Glutamate signalling through the N‐methyl‐d‐aspartate receptor (NMDAR) activates the enzyme neuronal nitric oxide synthase (nNOS) to produce the signalling molecule nitric oxide (NO). We hypothesized that disruption of the protein–protein interaction between nNOS and the scaffolding protein postsynaptic density 95 kDa (PSD95) would block NMDAR‐dependent NO signalling and represent a viable therapeutic route to decrease opioid reward and relapse‐like behaviour without the unwanted side effects of NMDAR antagonists. We used a conditioned place preference (CPP) paradigm to evaluate the impact of two small‐molecule PSD95‐nNOS inhibitors, IC87201 and ZL006, on the rewarding effects of morphine. Both IC87201 and ZL006 blocked morphine‐induced CPP at doses that lacked intrinsic rewarding or aversive properties. Furthermore, in vivo fast‐scan cyclic voltammetry (FSCV) was used to ascertain the impact of ZL006 on morphine‐induced increases in dopamine (DA) efflux in the nucleus accumbens shell (NAc shell) evoked by electrical stimulation of the medial forebrain bundle (MFB). ZL006 attenuated morphine‐induced increases in DA efflux at a dose that did not have intrinsic effects on DA transmission. We also employed multiple intravenous drug self‐administration approaches to examine the impact of ZL006 on the reinforcing effects of morphine. Interestingly, ZL006 did not alter acquisition or maintenance of morphine self‐administration, but reduced lever pressing in a morphine relapse test after forced abstinence. Our results provide behavioural and neurochemical support for the hypothesis that inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse‐like behaviour, highlighting a previously unreported application for these novel therapeutics in the treatment of opioid addiction.

Involvement of the Insular Nitric Oxide Signaling Pathway in the Expression of Morphine-Induced Conditioned Place Preference in Rats

The NO/sGC/PKG Signaling Pathway in the NAc Shell is Necessary for the Acquisition of Morphine-Induced Place Preference.

Role of the No/Sgc/Pkg Signaling Pathway of Hippocampal Ca1 in Morphine-Induced Reward Memory

Involvement of Insular Muscarinic Cholinergic Receptors in Morphine-Induced Conditioned Place Preference in Rats.

The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats.

Essential Role of the NO Signaling Pathway in the Hippocampal CA1 in Morphine-Associated Memory Depends on Glutaminergic Receptors

Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats

Inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse vulnerability in rats

Brain opioid-receptors are involved in mediating peripheral electric stimulation-induced inhibition of morphine conditioned place preference in rats

The differential effects of OX1R and OX2R selective antagonists on morphine conditioned place preference in naïve versus morphine-dependent mice

Dose- and Time-Dependent, Context-Induced Elevation of Dopamine and Its Metabolites in the Nucleus Accumbens of Morphine-Induced CPP Rats

Peripheral Electrical Stimulation-Induced Suppression of Morphine-Induced CCP in Rats: A Role for Dopamine in the Nucleus Accumbens

Upregulation of HCN2 in ventral tegmental area is involved in morphine‐induced conditioned place preference in rats

Reactivation of Morphine Conditioned Place Preference by Drug Priming: Role of Environmental Cues and Sensitization

Effect of NR2B Antisense Oligonucleotide on Naloxone-Induced Withdrawal Responses in Morphine-Dependent Rats

Blockade of Cannabinoid CB1 Receptor Attenuates the Acquisition of Morphine-Induced Conditioned Place Preference along with a Downregulation of ERK, CREB Phosphorylation, and BDNF Expression in the Nucleus Accumbens and Hippocampus.

Endogenous histamine inhibits the development of morphine-induced conditioned place preference

The Possible Involvement of Endogenous Ligands for Mu-, Delta- and Kappa-Opioid Receptors in Modulating Morphine-Induced CPP Expression in Rats

Cannabinoid 1 Receptor Blockade in the Dorsal Hippocampus Prevents the Reinstatement but Not Acquisition of Morphine-Induced Conditioned Place Preference in Rats

Morphine Coordinates SST and PV Interneurons in the Prelimbic Cortex to Disinhibit Pyramidal Neurons and Enhance Reward

Role of Nociceptin in the Modulation of Nociception in the Arcuate Nucleus of Rats